CollPlant Biotechnologies (CLGN) Cash from Financing Activities (2018 - 2024)
CollPlant Biotechnologies (CLGN) posted Cash from Financing Activities of $9000.0 for Q1 2024, down 95.83% on a QoQ basis from $216000.0 in Q3 2023, and down 98.88% year-over-year from $803000.0 in Q2 2023.
CollPlant Biotechnologies (CLGN) Cash from Financing Activities (2018 - 2024) Analysis & Trends
CollPlant Biotechnologies' Cash from Financing Activities history runs 7 years deep, the most recent figure standing at $9000.0 for Q1 2024.
- Quarterly Cash from Financing Activities fell 98.88% year-over-year to $9000.0 in Q1 2024, while the trailing twelve-month figure through Dec 2024 was $9000.0 (down 99.19% YoY) and the FY2025 annual result came in at $3.1 million, up 34366.67% from the prior year.
- Cash from Financing Activities was $9000.0 for Q1 2024 at CollPlant Biotechnologies, down from $216000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $35.5 million in Q1 2021 and bottomed at -$54000.0 in Q2 2020.
- A 5-year average of $3.3 million and a median of $308000.0 in 2022 frame the typical range for Cash from Financing Activities.
- Peak annual rise in Cash from Financing Activities reached 21571.43% in 2020, while the deepest fall reached 1900.0% in 2020.
- CollPlant Biotechnologies' Cash from Financing Activities stood at -$6000.0 in 2020, then soared by 2466.67% to $142000.0 in 2021, then soared by 181.69% to $400000.0 in 2022, then tumbled by 46.0% to $216000.0 in 2023, then sank by 95.83% to $9000.0 in 2024.
- Business Quant data shows CLGN's Cash from Financing Activities at $9000.0 in Q1 2024, $216000.0 in Q3 2023, and $89000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 30.14 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 53,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 68.63 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -538.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -802.20 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 238.74 Mn |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 9,000.00 |
| Mar 31, 2024 | 9,000.00 |
| Sep 30, 2023 | 216,000.00 |
| Sep 30, 2023 | 216,000.00 |
| Jun 30, 2023 | 89,000.00 |
| Jun 30, 2023 | 89,000.00 |
| Mar 31, 2023 | 803,000.00 |
| Mar 31, 2023 | 803,000.00 |
| Dec 31, 2022 | 400,000.00 |
| Dec 31, 2022 | 400,000.00 |
| Mar 31, 2022 | 1.47 Mn |
| Mar 31, 2022 | 1.47 Mn |
| Dec 31, 2021 | 142,000.00 |
| Dec 31, 2021 | 142,000.00 |
| Sep 30, 2021 | 1.75 Mn |
| Sep 30, 2021 | 1.75 Mn |
| Jun 30, 2021 | 1.36 Mn |
| Jun 30, 2021 | 1.36 Mn |
| Mar 31, 2021 | 35.51 Mn |
| Mar 31, 2021 | 35.51 Mn |